Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advancement of HDAC inhibitors against breast cancer
Syed Abdulla Mehmood, Kantrol Kumar Sahu, Sounok Sengupta, et al.
Medical Oncology (2023) Vol. 40, Iss. 7
Closed Access | Times Cited: 14

Showing 14 citing articles:

Emerging therapeutic strategies in cancer therapy by HDAC inhibition as the chemotherapeutic potent and epigenetic regulator
Dipanjan Karati, Swarupananda Mukherjee, Souvik Roy
Medical Oncology (2024) Vol. 41, Iss. 4
Closed Access | Times Cited: 9
Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment
Linlin Zhou, Danny Yu
Pharmacological Research (2024) Vol. 204, pp. 107205-107205
Open Access | Times Cited: 9
Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents
Milan Beljkaš, Dušan Ružić, Ana Djurić, et al.
Future Medicinal Chemistry (2025), pp. 1-15
Closed Access
Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives
Ibrahim S. Alalhareth, Saleh M. Alyami, Abdulrhman Alshareef, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 207-207
Open Access
Unveiling Epigenetic Vulnerabilities in Triple-Negative Breast Cancer through 3D Organoid Drug Screening
Xinxin Rao, Zhibin Qiao, Yang Yang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 225-225
Open Access | Times Cited: 5
Trifluoromethyl quinoline derivative targets inhibiting HDAC1 for promoting the acetylation of histone in cervical cancer cells
Ting Zhang, Changhua Zhou, Mengfan Lv, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 194, pp. 106706-106706
Open Access | Times Cited: 2
Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells
Peter Wai Tik Lee, Lina Rochelle Koseki, Takao Haitani, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1729-1729
Open Access | Times Cited: 2
Impact of HDAC6-mediated progesterone receptor expression on the response of breast cancer cells to hormonal therapy
Wafaa S. Ramadan, Rahma K. Alseksek, Soraya Mouffak, et al.
European Journal of Pharmacology (2024), pp. 177001-177001
Closed Access | Times Cited: 1
Discovery, lead identification and exploration of potential oxadiazole derivatives in targeting STAT3 as anti-cancer agents
Vivek Panwar, Sounok Sengupta, Saroj Kumar, et al.
In Silico Pharmacology (2024) Vol. 12, Iss. 2
Closed Access | Times Cited: 1
Deacetylation of Histones and Non-histone Proteins in Inflammatory Diseases and Cancer Therapeutic Potential of Histone Deacetylase Inhibitors
Ezgi Man, Serap Evran
Current Genomics (2023) Vol. 24, Iss. 3, pp. 136-145
Open Access | Times Cited: 3
Design and optimization of novel Tetrahydro-β-carboline-based HDAC inhibitors with potent activities against tumor cell growth and metastasis
Shule Fan, Zeyi Wan, Yuhua Qu, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 114, pp. 129986-129986
Closed Access
ResisenseNet hybrid neural network model for predicting drug sensitivity and repurposing in breast Cancer
Anush Karampuri, Bharath Kumar Jakkula, Perugu Shyam
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Unlocking Macrophage Secrets: Histone Deacetylases in Chronic Transplant Rejection
Marta Hałasa, Anna Wawruszak
Results and problems in cell differentiation (2024), pp. 297-313
Closed Access
Identification of UBFD1 as a prognostic biomarker and molecular target among estrogen receptor-positive breast cancer
Lian Duan, Rui Liu, Xiaoyue Cui, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 686, pp. 149171-149171
Open Access | Times Cited: 1
MHY446 induces apoptosis via reactive oxygen species-mediated endoplasmic reticulum stress in HCT116 human colorectal cancer cells
Yu Ra Ahn, Jung Yoon Jang, Yong Jung Kang, et al.
Journal of Chemotherapy (2023) Vol. 36, Iss. 6, pp. 483-500
Closed Access | Times Cited: 1
Page 1

Scroll to top